Catégorie
Deferoxamine
Numéro CAS
Deferoxamine STD-70-51-9;138-14-7(Mesylate): IMP-F-3031015-22-9: IMP-H-NA: IMP-I-2991819-68-0: IMP-J-1623757-38-9: IMP-K-NA
Formule moléculaire
Deferoxamine STD-C25H48N6O8: IMP-F-C25H48N6O7: IMP-H-C41H78N10O12: IMP-I-C23H46N6O6: IMP-J-C34H64N8O11: IMP-K-C48H91N11O14
Masse moléculaire
Deferoxamine STD-560.68: IMP-F-544.69: IMP-H-903.13: IMP-I-502.66: IMP-J-760.93: IMP-K-1046.32
Synonyme

Deferoxamine STD-N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide; N1-(5-Aminopentyl)-N1-hydroxy-N4-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]butanediamide; N-[5-[3-[(5-Aminopentyl)hydroxycarbamoyl]propionamido]pentyl]-3-[[5-(N-hydroxyacetamido)pentyl]carbamoyl]propionohydroxamic Acid;N1-(5-Aminopentyl)-N1-hydroxy-N4-(5-(N-hydroxy-4-((5-(N-hydroxyacetamido)pentyl)amino)-4-oxobutanamido)pentyl)succinamide; Deferoxamine B; Deferoxamine; Deferrioxamine B; Desferal mesylate; Desferrioxamine B; Desferrioxamine

Deferoxamine EP-Impurity-F-N1-(5-Acetamidopentyl)-N4-[5-[4-[(5-aminopentyl)-(hydroxyl)amino]-4-oxobutanamido]pentyl]-N4-hydroxybutanediamide; N1-(5-Acetamidopentyl)-N4-(5-(4-((5-aminopentyl)(hydroxy)amino)-4-oxobutanamido)pentyl)-N4-hydroxysuccinamide

Deferoxamine EP-Impurity-H-N1,N1'-(6,22-Dihydroxy-7,10,18,21-tetraoxo-6,11,17,22-tetraazaheptacosane-1,27-diyl)bis(N4-(5-aminopentyl)-N4-hydroxysuccinamide); N1,N37-Bis(5-aminopentyl)-N1,N37,11,27-tetrahydroxy-4,12,15,23,26,34-hexaoxo-5,11,16,22,27,33-hexaazaheptatriacontane-1,37-diamide

Deferoxamine EP-Impurity-I-N1-(5-Aminopentyl)-N4-[5-(4-[(5-aminopentyl)-(hydroxy)amino]-4-oxobutanamido)pentyl]-N1-hydroxybutanediamide; N1,N1'-(Pentane-1,5-diyl)bis(N4-(5-aminopentyl)-N4-hydroxysuccinamide)

Deferoxamine EP-Impurity-J-N-[5-[[4-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide; N1-(27-Amino-11,22-dihydroxy-7,10,18,21-tetraoxo-6,11,17,22-tetraazaheptacosyl)-N1-hydroxy-N4-(5-(N-hydroxyacetamido)pentyl)succinamide

Deferoxamine EP-Impurity-K-N1,N1'-(17-Acetoxy-6,28-dihydroxy-7,10,24,27-tetraoxo-6,11,17,23,28-pentaazatritriacontane-1,33-diyl)bis(N4-(5-aminopentyl)-N4-hydroxysuccinamide); 22-(Acetyloxy)-N1,N43-bis(5-aminopentyl)-N1,N43,11,33-tetrahydroxy-4,12,15,29,32,40-hexaoxo-5,11,16,22,28,33,39-heptaazatritetracontane-1,43-diamide

slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Deferoxamine for Peak Identification CRS is a certified reference standard used in analytical laboratories to accurately identify the deferoxamine peak in techniques like HPLC or GC. It ensures correct retention time matching, method validation, and reliable quality control when analyzing deferoxamine in pharmaceutical formulations or research samples.